Do Anxiety and Distress Increase During Active Surveillance for Low Risk Prostate Cancer?

Journal of Urology

Volumn 183, Issue 5, 2010, Pages 1786-1791

  van den Bergh, Roderick C N ^a   Essink Bot, Marie Louise ^a,b   Roobol, Monique J ^a   Schröder, Fritz H ^a   Bangma, Chris H ^a   Steyerberg, Ewout W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

anxiety; prostate; prostatic neoplasms; quality of life; questionnaires

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ANXIETY DISORDER; ARTICLE; CANCER GROWTH; CANCER RISK; CONTROLLED STUDY; DEPRESSION; DISEASE SURVEILLANCE; DISTRESS SYNDROME; EYSENCK PERSONALITY QUESTIONNAIRE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NEUROSIS; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; RATING SCALE; SHORT FORM 12; STATE TRAIT ANXIETY INVENTORY;

ANXIETY; DISEASE PROGRESSION; FEAR; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NETHERLANDS; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; STRESS, PSYCHOLOGICAL;

EID: 77950517980     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.12.099     Document Type: Article

References (29)

1. Parker C. Active surveillance: towards a new paradigm in the management of early prostate cancer. Lancet Oncol 5 (2004) 101
2. Cooperberg M.R., Broering J.M., Kantoff P.W., et al. Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol 178 (2007) S14
3. van den Bergh R.C., Roemeling S., Roobol M.J., et al. Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly. Eur Urol 55 (2009) 1
4. van den Bergh R.C., Essink-Bot M.L., Roobol M.J., et al. Anxiety and distress during active surveillance for early prostate cancer. Cancer 115 (2009) 3868
5. Wallace M. Uncertainty and quality of life of older men who undergo watchful waiting for prostate cancer. Oncol Nurs Forum 30 (2003) 303
6. Clark J.A., Inui T.S., Silliman R.A., et al. Patients' perceptions of quality of life after treatment for early prostate cancer. J Clin Oncol 21 (2003) 3777
7. Latini D.M., Hart S.L., Knight S.J., et al. The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance. J Urol 178 (2007) 826
8. van den Bergh R.C., Roemeling S., Roobol M.J., et al. Prospective validation of active surveillance in prostate cancer: the PRIAS study. Eur Urol 52 (2007) 1560
9. O'Connor A.M. Validation of a decisional conflict scale. Med Decis Making 15 (1995) 25
10. Roberts R.E., and Vernon S.W. The Center for Epidemiologic Studies Depression Scale: its use in a community sample. Am J Psychiatry 140 (1983) 41
11. Marteau T.M., and Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol 31 (1992) 301
12. Roth A.J., Rosenfeld B., Kornblith A.B., et al. The Memorial Anxiety Scale for Prostate Cancer: validation of a new scale to measure anxiety in men with prostate cancer. Cancer 97 (2003) 2910
13. Ware Jr. J., Kosinski M., and Keller S.D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34 (1996) 220
14. Eysenck H.J., and Eysenck S.B.G. Manual of the Eysenck Personality Scales (EPS Adult) (1991), Hodder & Stoughton, London
15. Beekman A.T., van Limbeek J., Deeg D.J., et al. A screening tool for depression in the elderly in the general population: the usefulness of Center for Epidemiological Studies Depression Scale (CES-D). Tijdschr Gerontol Geriatr 25 (1994) 95
16. Koedoot N., Molenaar S., Oosterveld P., et al. The decisional conflict scale: further validation in two samples of Dutch oncology patients. Patient Educ Couns 45 (2001) 187
17. Razavi D., and Gandek B. Testing Dutch and French translations of the SF-36 Health Survey among Belgian angina patients. J Clin Epidemiol 51 (1998) 975
18. Sanderman R., Arindell W.A., Ranchor A.V., et al. Het meten van persoonlijkheidskenmerken met de Eysenck Personality Questionnaire (EPQ): een handleiding. Noordelijk centrum voor gezondheidsvraagstukken (1995), Rijksuniversiteit Groningen, Groningen, The Netherlands
19. van den Bergh R.C., Korfage I.J., Borsboom G.J., et al. Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the Memorial Anxiety Scale for Prostate Cancer. Qual Life Res 18 (2009) 1061
20. van der Bij A.K., de Weerd S., Cikot R.J., et al. Validation of the Dutch short form of the state scale of the Spielberger State-Trait Anxiety Inventory: considerations for usage in screening outcomes. Commun Genet 6 (2003) 84
21. Norman G.R., Sloan J.A., and Wyrwich K.W. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41 (2003) 582
22. Nijrolder I., van der Windt D., and van der Horst H. Prediction of outcome in patients presenting with fatigue in primary care. Br J Gen Pract 59 (2009) e101
23. Chapple A., Ziebland S., Herxheimer A., et al. Is 'watchful waiting' a real choice for men with prostate cancer?. A qualitative study. BJU Int 90 (2002) 257
24. Pickles T., Ruether J.D., Weir L., et al. Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance. BJU Int 100 (2007) 544
25. Burnet K.L., Parker C., Dearnaley D., et al. Does active surveillance for men with localized prostate cancer carry psychological morbidity?. BJU Int 100 (2007) 540
26. Blank T.O., and Bellizzi K.M. After prostate cancer: predictors of well-being among long-term prostate cancer survivors. Cancer 106 (2006) 2128
27. Korfage I.J., Essink-Bot M.L., Borsboom G.J., et al. Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer. Int J Cancer 116 (2005) 291
28. Schröder F.H., Hugosson J., Roobol M.J., et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360 (2009) 1320
29. Donovan J., Hamdy F., Neal D., et al. Prostate Testing for Cancer and Treatment (ProtecT) feasibility study. Health Technol Assess 7 (2003) 1